Experiment 626287
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Empty organism |
| Citation | CASTANO,G: MAS,R: ROCA,J: FERNANDEZ,L: ILLNAIT,J: FERNANDEZ,JC: SELMAN,E:. (1999). A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE EFFECTS OF POLICOSANOL IN PATIENTS WITH INTERMITTENT CLAUDICATION.. 50(2) |
| Amount utilized | |
| Compound isolated | |
| Disease | A CLINICAL TRIAL TO EVALUATE THE EFFICACY AND TOLERABILITY OF POLICOSANOL, A NEW CHOLESTEROL-LOWERING DRUG WITH CONCOMITANT ANTIPLATELET EFFECTS, IN PATIENTS WITH INTERMITTENT CLAUDICATION. AFTER A BASELINE PEROID OF 6 WEEKS, 62 PATIENTS WERE RANDOMIZED TO RECEIVE, UNDER DOUBLE-BLIND CONDITIONS, EITHER PLACEBO (31 PATIENTS) OR POLICOSANOL (31), 10 MG TWICE DAILY. WALKING DISTANCES IN A TREADMILL (CONSTANT SPEED 3.2 KM/HR, SLOPE 10 DEGREES) WERE ASSESSED BEFORE AND AFTER 6 MONTHS OF TREATMENT. |
| Dose amount | 20.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Gender | GIVEN TO BOTH SEXES |